These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 20154064)

  • 21. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
    Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
    Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
    Wang Y; Zhao X; Jin H; Wei H; Li W; Bu D; Tang X; Ren Y; Tang C; Du J
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):173-9. PubMed ID: 18988885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heat shock protein 90 inhibitor induces apoptosis and attenuates activation of hepatic stellate cells.
    Myung SJ; Yoon JH; Kim BH; Lee JH; Jung EU; Lee HS
    J Pharmacol Exp Ther; 2009 Jul; 330(1):276-82. PubMed ID: 19329756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat shock protein 90 inhibition by 17-DMAG attenuates abdominal aortic aneurysm formation in mice.
    Qi J; Yang P; Yi B; Huo Y; Chen M; Zhang J; Sun J
    Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H841-52. PubMed ID: 25637544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models.
    Banerji U; Walton M; Raynaud F; Grimshaw R; Kelland L; Valenti M; Judson I; Workman P
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7023-32. PubMed ID: 16203796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 17-Dimethylaminoethylamino-17-demethoxygeldanamycin attenuates inflammatory responses in experimental stroke.
    Qi J; Han X; Liu HT; Chen T; Zhang JL; Yang P; Bo SH; Lu XT; Zhang J
    Biol Pharm Bull; 2014; 37(11):1713-8. PubMed ID: 25366476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice.
    Yao R; Cheng X; Liao YH; Chen Y; Xie JJ; Yu X; Ding YJ; Tang TT
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):188-95. PubMed ID: 18287887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geldanamycin interferes with the 90-kDa heat shock protein, affecting lipopolysaccharide-mediated interleukin-1 expression and apoptosis within macrophages.
    Hsu HY; Wu HL; Tan SK; Li VP; Wang WT; Hsu J; Cheng CH
    Mol Pharmacol; 2007 Jan; 71(1):344-56. PubMed ID: 16868182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular heat shock protein 90 induces interleukin-8 in vascular smooth muscle cells.
    Chung SW; Lee JH; Choi KH; Park YC; Eo SK; Rhim BY; Kim K
    Biochem Biophys Res Commun; 2009 Jan; 378(3):444-9. PubMed ID: 19028451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulatory effects of heat shock protein 90 inhibition on humoral immune responses.
    Tukaj S; Tiburzy B; Manz R; de Castro Marques A; Orosz A; Ludwig RJ; Zillikens D; Kasperkiewicz M
    Exp Dermatol; 2014 Aug; 23(8):585-90. PubMed ID: 24961936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice.
    Byon CH; Han T; Wu J; Hui ST
    Atherosclerosis; 2015 Aug; 241(2):313-21. PubMed ID: 26062991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small interfering RNA knocks down heat shock factor-1 (HSF-1) and exacerbates pro-inflammatory activation of NF-kappaB and AP-1 in vascular smooth muscle cells.
    Chen Y; Currie RW
    Cardiovasc Res; 2006 Jan; 69(1):66-75. PubMed ID: 16061216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.
    Gareus R; Kotsaki E; Xanthoulea S; van der Made I; Gijbels MJ; Kardakaris R; Polykratis A; Kollias G; de Winther MP; Pasparakis M
    Cell Metab; 2008 Nov; 8(5):372-83. PubMed ID: 19046569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis.
    Chatterjee A; Dimitropoulou C; Drakopanayiotakis F; Antonova G; Snead C; Cannon J; Venema RC; Catravas JD
    Am J Respir Crit Care Med; 2007 Oct; 176(7):667-75. PubMed ID: 17615388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis.
    López-Franco O; Hernández-Vargas P; Ortiz-Muñoz G; Sanjuán G; Suzuki Y; Ortega L; Blanco J; Egido J; Gómez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1864-70. PubMed ID: 16741149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors.
    Ibrahim NO; Hahn T; Franke C; Stiehl DP; Wirthner R; Wenger RH; Katschinski DM
    Cancer Res; 2005 Dec; 65(23):11094-100. PubMed ID: 16322259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
    Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geldanamycin inhibits tyrosine phosphorylation-dependent NF-kappaB activation.
    Crèvecoeur J; Merville MP; Piette J; Gloire G
    Biochem Pharmacol; 2008 Jun; 75(11):2183-91. PubMed ID: 18455150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors.
    Centenera MM; Gillis JL; Hanson AR; Jindal S; Taylor RA; Risbridger GP; Sutherland PD; Scher HI; Raj GV; Knudsen KE; Yeadon T; ; Tilley WD; Butler LM
    Clin Cancer Res; 2012 Jul; 18(13):3562-70. PubMed ID: 22573351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes.
    Tukaj S; Grüner D; Zillikens D; Kasperkiewicz M
    Cell Stress Chaperones; 2014 Nov; 19(6):887-94. PubMed ID: 24796797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.